- Trials with a EudraCT protocol (5)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
5 result(s) found for: Aseptic meningitis.
Displaying page 1 of 1.
EudraCT Number: 2017-000429-10 | Sponsor Protocol Number: 17-030 | Start Date*: 2017-10-24 | |||||||||||
Sponsor Name:CHU CAEN | |||||||||||||
Full Title: FIVHeMA: Intraventricular fibrinolysis versus external ventricular drainage alone in aneurysmal subarachnoid hemorrhage: a randomized controlled trial. | |||||||||||||
Medical condition: Patients > 18 years, with aneurysmal SAH complicated by hydrocephalus, requiring insertion of external ventricular drainage | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) NO (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-001570-30 | Sponsor Protocol Number: D20-P013 | Start Date*: 2020-04-09 | |||||||||||
Sponsor Name:GHU PARIS PSYCHIATRIE ET NEUROSCIENCES | |||||||||||||
Full Title: Interest of early treatment with polyvalent immunoglobulins in the management of respiratory distress syndrome associated with SARS-CoV-2 infections_COVID-19 | |||||||||||||
Medical condition: Cov-2 SARS Disease | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-001393-34 | Sponsor Protocol Number: MNILCAPS001 | Start Date*: 2014-04-14 | |||||||||||
Sponsor Name:UZ Leuven | |||||||||||||
Full Title: IlarisĀ® (canakinumab) efficacy and safety in CAPS patients without confirmed mutation on exon 3 of gene CIAS1 and young (<2yrs) CAPS patients with severe neurological (CINCA) phenotype. | |||||||||||||
Medical condition: Cryopyrin-Associated Periodic Syndromes | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Children, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2021-001401-67 | Sponsor Protocol Number: APHP201152 | Start Date*: 2021-07-21 | |||||||||||
Sponsor Name:ASSISTANCE PUBLIQUE-HOPITAUX DE PARIS (APHP) | |||||||||||||
Full Title: Phase II trial to evaluate the combination of capmatinib + spartalizumab in advanced oesogastric adenocarcinoma | |||||||||||||
Medical condition: Patients with advanced oesogastric adenocarcinoma that have received at least one previous chemotherapy line with platinium salt and fluoropyrimidin and with a documented progression. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-003556-20 | Sponsor Protocol Number: RH4131-03 | Start Date*: 2014-02-19 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sponsor Name:Dept. of Intensive Care 4131, Copenhagen University Hospital, Rigshospitalet | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Full Title: Immunoglobulin for Necrotizing Soft Tissue Infections: a Randomised Controlled Trial | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Medical condition: Necrotizing Soft Tissue Infections | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Trial protocol: DK (Completed) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
